Both in vitro and in vivo studies have provided evidence that Ex-4 can significantly inhibit breast cancer cell proliferation by suppressing NF-κB signaling activation and the expression of its downstream target genes, vascular endothelial growth factor (VEGF) and interleukin-8(IL-8) [55]. The gene discussed is NFKB1; the disease is breast cancer.